Rovalpituzumab (Anti-DLL3)
A2521
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameRovalpituzumab (Anti-DLL3)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionRovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203